Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma

Immune checkpoint inhibitors (ICIs) are promising agents for treating melanoma. Given that autoimmune skin diseases exhibit hyper immune reaction, investigation of immune cells from autoimmune skin disease is crucial to validate the effectiveness of ICIs in melanoma treatment. We employed multipanel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Kyu-Hye, Park, Ye-Chan, Hwang, Nahee, Yoon, Bo Kyung, Kim, Jae-woo, Fang, Sungsoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497583/
https://www.ncbi.nlm.nih.gov/pubmed/37700026
http://dx.doi.org/10.1038/s41598-023-42238-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497583/
https://www.ncbi.nlm.nih.gov/pubmed/37700026
http://dx.doi.org/10.1038/s41598-023-42238-3

Ejemplares similares